$BIIB
Biogen Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Cambridge, MA
BIIB chart
What traders are saying about $BIIB
Latest postsBiogen Inc. news
- Two Neighbors Will Start Leqembi, Listed at $28,270 a Year. One With Medigap Plan G Will Owe $0 in Coinsurance After the Part B Deductible, While the Other Will Owe 20% of Medicare-Approved Infusion Costs
247wallst.com ·
- Biogen to Participate in the Jefferies Global Healthcare Conference
Biogen ·
- CPI | Dutch Regulators Probe Biogen Over MS Treatment Competition
PYMNTS.com ·
- Stifel's Paul Matteis: Biogen's lupus readouts, a strange psilocybin filing and biotech's rising political risk
BigGo Finance ·
- Dutch antitrust regulators probe Biogen over test for its MS drug
STAT ·
- One institution reports owning 7.57 million Biogen (BIIB) shares.
Stock Titan ·
- 3 Biotech Stocks To Watch As US Policy Support Comes Into Focus
Simply Wall St ·
- Biogen Inc. (BIIB) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Biogen Inc. stock outperforms competitors on strong trading day
MarketWatch ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- Biogen Inc. (BIIB) stock price, news, quote and history
Yahoo Finance UK ·
- Awards
Modern Healthcare ·
Biogen Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $9.89B | $9.68B | $9.84B | $10.17B |
| Net income | $1.29B | $1.63B | $1.16B | $3.05B |
| Diluted EPS | $8.79 | $11.18 | $7.97 | $20.87 |
| Total assets (year end) | $29.44B | $28.05B | $26.84B | $24.55B |
| Cash and equivalents (year end) | – | – | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Biogen Inc.
- Ticker
- BIIB (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 875045
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE
Frequently asked questions
What exchange is Biogen Inc. listed on?
Biogen Inc. trades on the Nasdaq under the ticker symbol BIIB.
What industry is Biogen Inc. in?
Biogen Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Biogen Inc. headquartered?
Biogen Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Biogen Inc.'s fiscal year end?
Biogen Inc.'s fiscal year ends on December 31.
How much revenue did Biogen Inc. report?
Biogen Inc. reported $9.89B in revenue for calendar year 2025, according to its SEC filings.